Info

OTCQB Podcast

OTC Markets Group podcast series on the OTCQB Market, where we interview the entrepreneurs behind the companies that trade on the venture market.
RSS Feed
OTCQB Podcast
2022
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February


2017
December
November
October
September
August
July
June
May
April
March
January


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Mar 5, 2018

Wize Pharma (OTCQB: WIZPD) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including Dry Eye Syndrome. Wize Pharma has inlicensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of Dry Eye Syndrome, and other ophthalmological illnesses, including Sjorgen's Syndrome and Conjunctivochalasis.

0 Comments
Adding comments is not available at this time.